Three year follow-up of body composition changes in pre-menopausal women with systemic lupus erythematosus

Rheumatology

Volumn 38, Issue 1, 1999, Pages 59-65

  Kipen, Y ^a,c   Briganti, E M ^b   Strauss, B J G ^c   Littlejohn, G O ^a   Morand, E E ^b  

^a MONASH UNIVERSITY   (Australia)

^b MONASH UNIVERSITY   (Australia)

^c MONASH MEDICAL CENTRE   (Australia)

Author keywords

Body composition; Corticosteroid therapy; Systemic lupus erythematosus

Indexed keywords

CORTICOSTEROID; PREDNISOLONE;

ADULT; ARTICLE; BODY COMPOSITION; BODY MASS; BONE DENSITY; BONE MINERAL; CLINICAL ARTICLE; CORTICOSTEROID THERAPY; DISEASE ACTIVITY; DUAL ENERGY X RAY ABSORPTIOMETRY; EXERCISE; FEMALE; FOLLOW UP; HEALTH; HUMAN; PREDICTION; PREMENOPAUSE; PRIORITY JOURNAL; QUESTIONNAIRE; REGRESSION ANALYSIS; SMOKING; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADULT; BODY COMPOSITION; BONE DENSITY; CROSS-SECTIONAL STUDIES; DENSITOMETRY, X-RAY; FEMALE; FOLLOW-UP STUDIES; GLUCOCORTICOIDS; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; PREDNISOLONE; PREMENOPAUSE; SEVERITY OF ILLNESS INDEX;

EID: 0032752686     PISSN: 14620324     EISSN: None     Source Type: Journal    
DOI: 10.1093/rheumatology/38.1.59     Document Type: Article

References (40)

1. Wang ZM, Heshka S, Pierson RN, Heymsfield SB. Systematic organization of body composition methodology: an overview with emphasis on component-based methods. Am J Clin Nutr 1995;61:457-65.
2. Mazess RB, Barden HS, Bisek JP, Hanson J. Dual energy x-ray absorptiometry for total body and regional bone mineral and regional soft tissue composition. Am J Clin Nutr 1990;51:1106-12.
3. Svendsen OL, Haarbo J, Hassager C, Christiansen C. Accuracy of measurements of body composition by dual energy x-ray absorptiometry in vivo. Am J Clin Nutr 1993;57:605-8.
4. Jensen MD, Kanaley JA, Roust LR et al. Assessment of body composition with use of dual energy x-ray absorptiometry: evaluation and comparison with other methods. Mayo Clin Proc 1993;68:867-73.
5. Roubenoff R, Roubenoff RA, Ward LM, Holland MS, Hellmann DB. Rheumatoid cachexia: Depletion of lean body mass in rheumatoid arthritis. Possible association with tumor necrosis factor. J Rheumatol 1992;19:1505-10.
6. Roubenoff R, Roubenoff RA, Ward LM, Stevens MB. Catabolic effects of high dose corticosteroids persist despite therapeutic benefit in rheumatoid arthritis. Am J Clin Nutr 1990;52:113-7.
7. Roubenoff R, Rall LC. Humoral mediation of changing body composition during aging and chronic inflammation. Nutr Rev 1993;51:1-11.
8. Westhovens R, Nijs J, Taelman V, Dequeker J. Body composition in rheumatoid arthritis. Br J Rheumatol 1997;36:444-8.
9. Sambrook PH, Spector TD, Seeman E et al. Osteoporosis in rheumatoid arthritis. Arthritis Rheum 1995;38:806-9.
10. Munro R, Campbell H. Prevalence of low body mass in rheumatoid arthritis: association with the acute phase response. Ann Rheum Dis 1997;56:326-9.
11. Baxter JD, Forsham PH. Tissue effects of glucocorticoids. Am J Med 1972;53:573-89.
12. Kotler DP, Tierney AR, Wang J, Pierson RN. Magnitude of body-cell-mass depletion and the timing of death from wasting in AIDS. Am J Clin Nutr 1989;50:444-7.
13. Tellado JM, Garcia-Sabrido JL, Hanley JA, Shizgal HM, Christou NV. Predicting mortality based on body composition analysis. Ann Surg 1989;209:81-7.
14. DeWys WD, Begg C, Lavin PT et al. Prognostic effect of weight loss prior to chemotherapy in cancer patients. Am J Med 1980;69:491-7.
15. Chandra S, Chandra RK. Nutrition, immune response, and outcome. Prog Food Nutr Sci 1986;10:1-65.
16. Chandra RK. 1990 McCollum award lecture. Nutrition and immunity: lessons from the past and new insights into the future. Am J Clin Nutr 1991;53:1087-101.
17. Tanaka Y, Watanabe K, Suzuki M et al. Spontaneous production of bone-resorbing lymphokines by B cells in patients with systemic lupus erythematosus. J Clin Immunol 1989;9:415-20.
18. Kipen Y, Strauss BJG, Morand EF. Body composition in systemic lupus erythematosus. Br J Rheumatol 1998;37:514-9.
19. Tan EM, Cohen AS, Fries JF et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982;25:1271-7.
20. Pincus T, Summey JA, Soraci SA, Wallston KA, Hummon NP. Assessment of patient satisfaction in activities of daily living using a modified Stanford health assessment questionnaire. Arthritis Rheum 1983;26:1346-53.
21. Liang MH, Socher SA, Larson MG, Schur PH. Reliability and validity of six systems for the clinical assessment of disease activity in systemic lupus erythematosus. Arthritis Rheum 1989;32:1107-18.
22. Gladman D, Ginzler E, Goldsmith C et al. The development and initial validation of the SLICC/ACR damage index for SLE. Arthritis Rheum 1996;39:363-9.
23. Houssiau FA, Lefebvre C, Depresseux G, Lambert M, Dcvogelaer J-P, Nagant de Deuxchaisnes C. Trabecular and cortical bone loss in systemic lupus erythematosus. Br J Rheumatol 1996;35:244-7.
24. Pons F, Peris P, Guanabens N et al. The effect of systemic lupus erythematosus and long-term steroid therapy on bone mass in pre-menopausal women. Br J Rheumatol 1995;34:742-6.
25. Formiga F, Nolla JM, Moga I, Roig-Escofet D. Sequential study of bone mineral density in patients with systemic lupus erythematosus. Ann Rheum Dis 1996;55:857.
26. Kalla AA, Fataas AB, Jeqsop SJ, Bewerunge L. Loss of trabecular bone mineral density in systemic lupus erythematosus. Arthritis Rheum 1993;36:1726-34.
27. Formiga F, Moga I, Nolla JM, Pac M, Mitjavila F, Roig-Escofet D. Loss of bone mineral density in premenopausal women with systemic lupus erythematosus. Ann Rheum Dis 1995;54:274-6.
28. Petri M. Musculoskeletal complications of systemic lupus erythematosus in the Hopkins lupus cohort: an update. Arthritis Care Res 1995;8:137-45.
29. Kipen Y, Buchbinder R, Strauss BJG, Forbes A, Littlejohn GO, Morand EF. Prevalence of reduced bone mineral density in systemic lupus erythematosus and the role of glucocorticoids. J Rheumatol 1997;24:1922-9.
30. Adinoff AD, Hollister JR. Steroid-induced fractures and bone loss in patients with asthma. N Engl J Med 1983;309:265-8.
31. Gough AKS, Lilley J, Eyre S, Holder RL, Emery P. Generalised bone loss in patients with early rheumatoid arthritis. Lancet 1994;344:23-7.
32. Pollock ML, Wilmore JH. Body composition alterations with exercise. In: Exercise in health and disease, 2nd edn. Philadelphia: WB Saunders, 1990:161-201.
33. Ulrich CM, Georgiou CC, Snow-Harter CM, Gillis DE. Bone mineral density in mother-daughter pairs: relations to lifetime exercise, lifetime milk consumption, and calcium supplements. Am J Clin Nutr 1996;63:72-9.
34. Lohman T, Going S, Pamenter R et al. Effects of resistance training on regional and total bone mineral density in premenopausal women: a randomised prospective study. J Bone Miner Res 195;10:1015-24.
35. Rall LC, Roubenoff R. Body composition, metabolism, and resistance exercise in patients with rheumatoid arthritis. Arthritis Care Res 1996;9:151-6.
36. Hopper JL, Seeman E. The bone density of female twins discordant for tobacco use. N Engl J Med 1994;330: 387-92.
37. Mazess RB, Barden HS. Bone density in premenopausal women: effects of age, dietary intake, physical acitvity, smoking, and birth control pills. Am J Clin Nutr 1991;53:132-42.
38. Young D, Hopper JL, Nowson CA et al. Determinants of bone mass in 10- to 26-year-old females: a twin study. J Bone Miner Res 1995;10:558-67.
39. Aloia JF, Vaswani A, Ma R, Flaster E. To what extent is bone mass determined by fat free or fat mass. Am J Clin Nutr 1995;61:110-4.
40. Reid IR, Plank LD, Evans MC. Fat mass is an important determinant of whole body bone density in premenopausal women but not in men. J Clin Endocrinol Metab 1992;75:779-72.